News

$VYNE Therapeutics (VYNE.US)$ Reuters· 1 min ago
Vyne Therapeutics Inc: Positive Phase 1a Sad Data for Vyn202, a Novel BD2-Selective Bet Inhibitor! well tolerated. No adverse events

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate